EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications

Yoshinobu Kariya, Michiru Nishita

International Journal of Molecular Sciences · 28.03.2025 · 26 (7) · 3143

DOI: 10.3390/ijms26073143 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.03.2025. Verfasst von Yoshinobu Kariya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Fukushima Medical University, 1 Hikarigaoka, Fukushima City 960-1295, Fukushima, Japan. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Integrins, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for Promotion of Science KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is estimated that between 80 and 90% of mortality in cancer patients is directly or indirectly related to drug resistance. Consequently, overcoming drug resistance represents a significant challenge in the treatment of cancer. Integrins are transmembrane adhesion molecules that facilitate the linkage between the extracellular matrix (ECM) and the cytoskeleton, thereby enabling the activation of various cellular signaling pathways. Integrins are highly expressed in various cancers and contribute to cancer progression through invasion and metastasis. In addition, recent studies have revealed that integrins play a pivotal role in the development of drug resistance in cancer. This review will first provide an overview of integrin function and classification. It then discusses recent advances in understanding how integrins contribute to drug resistance in cancer, with a focus on ECM, drug transporters, the epithelial-to-mesenchymal transition (EMT), cancer stemness, PD-L1, and glycosylation. Finally, the potential applications of integrins as targets for therapeutic agents against drug-resistant cancers are also summarized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmIntegrinsNeoplasmsHumansEpithelial-Mesenchymal TransitionAnimalsAntineoplastic AgentsExtracellular MatrixSignal Transduction

Stichwörter der Autor:innen

PD-L1cancercancer stem cell (CSC)drug resistancedrug transporterepithelial-to-mesenchymal transition (EMT)extracellular matrix (ECM)glycosylationintegrintyrosine kinase inhibitor (TKI)

Substanzen

IntegrinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biochemistry, Fukushima Medical University, 1 Hikarigaoka, Fukushima City 960-1295, Fukushima, Japan.

Förderung

  • Japan Society for Promotion of Science KAKENHI

Zitieren

APA

Kariya, Y., & Nishita, M. (2025). Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications. International Journal of Molecular Sciences, 26(7), 3143. https://doi.org/10.3390/ijms26073143

Vancouver

Kariya Y, Nishita M. Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications. International Journal of Molecular Sciences. 2025;26(7):3143. doi:10.3390/ijms26073143

BibTeX
@article{Kariya2025,
  author = {Kariya, Yoshinobu and Nishita, Michiru},
  title = {Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {7},
  pages = {3143},
  doi = {10.3390/ijms26073143}
}
Kostenlos starten →